Characterization of mENT1Δ11, a novel alternative splice variant of the mouse equilibrative nucleoside transporter 1

Molecular Pharmacology

Volumn 74, Issue 1, 2008, Pages 264-273

  Robillard, Kevin R ^a,b   Bone, Derek B J ^a   Park, Jamie S ^a   Hammond, James R ^a,c  

^a WESTERN UNIVERSITY   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

2 CHLOROADENOSINE; EQUILIBRATIVE NUCLEOSIDE TRANSPORTER 1; EQUILIBRATIVE NUCLEOSIDE TRANSPORTER 1 DELTA 11; N ETHYLMALEIMIDE; NITROBENZYLTHIOINOSINE; TRITIUM; URIDINE; ISOPROTEIN; NUCLEOSIDE TRANSPORTER; SLC29A1 PROTEIN, MOUSE;

ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; EXON; GENE SEQUENCE; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; NUCLEOSIDE TRANSPORT; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN MODIFICATION; PROTEIN STRUCTURE; PROTEIN VARIANT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA PROCESSING; RNA SPLICING; TISSUE DISTRIBUTION; ALTERNATIVE RNA SPLICING; AMINO ACID SEQUENCE; ANIMAL; C57BL MOUSE; CELL LINE; CHEMISTRY; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; GENETICS; KINETICS; MALE; METABOLISM; MOLECULAR GENETICS; PLASMID; SWINE; TUMOR CELL LINE;

ALTERNATIVE SPLICING; AMINO ACID SEQUENCE; ANIMALS; CELL LINE; CELL LINE, TUMOR; EQUILIBRATIVE NUCLEOSIDE TRANSPORTER 1; KINETICS; MALE; MICE; MICE, INBRED C57BL; MOLECULAR SEQUENCE DATA; NUCLEOSIDE TRANSPORT PROTEINS; PLASMIDS; PROTEIN ISOFORMS; SWINE; TISSUE DISTRIBUTION; TRANSCRIPTION, GENETIC; TRANSFECTION;

EID: 45749142058     PISSN: 0026895X     EISSN: 15210111     Source Type: Journal    
DOI: 10.1124/mol.107.041871     Document Type: Article

References (30)

1. Baldwin SA, Beal PR, Yao SY, King AE, Cass CE, and Young JD (2004) The equilibrative nucleoside transporter family, SLC29. Pflugers Arch 447:735-743.
2. Bone DB, Robillard KR, Stolk M, and Hammond JR (2007) Differential regulation of mouse equilibrative nucleoside transporter 1 (MENT1) splice variants by protein kinase CK2. Mol Membr Biol 24:294-303.
3. Boumah CE, Hogue DL, and Cass CE (1992) Expression of high levels of nitrobenzylthioinosine-sensitive nucleoside transport in cultured human choriocarcinoma (BeWo) cells. Biochem J 288:987-996.
4. Cheng Y and Prusoff WH (1973) Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction. Biochem Pharmacol 22:3099-3108.
5. Coe I, Zhang Y, McKenzie T, and Naydenova Z (2002) PKC regulation of the human equilibrative nucleoside transporter, HENT1. FEBS Lett 517:201-205.
6. Coe IR, Griffiths M, Young JD, Baldwin SA, and Cass CE (1997) Assignment of the human equilibrative nucleoside transporter (HENT1) to 6p21.1-P21.2. Genomics 45:459-460.
7. Griffiths M, Beaumont N, Yao SYM, Sundaram M, Boumah CE, Davies A, Kwong FYP, Coe I, Cass CE, Young JD, et al. (1997) Cloning of a human nucleoside transporter implicated in the cellular uptake of adenosine and chemotherapeutic drugs. Nature Med 3:89-93.
8. 3H]nitrobenzylthioinosine binding site. Mol Pharmacol 39:771-779.
9. Hammond JR and Archer RG (2004) Interaction of the novel adenosine uptake inhibitor 3-[1-(6,7-diethoxy-2-morpholinoquinazolin-4-yl)piperidin-4-yl]-1,6- dimethyl-2,4 (1H,3H)-quinazolinedione hydrochloride (KF24345) with the Es and Ei subtypes of equilibrative nucleoside transporters. J Pharmacol Exp Ther 308:1083-1093.
10. Hammond JR and Johnstone RM (1989) Solubilization and reconstitution of a nucleoside-transport system from Ehrlich ascites-tumour cells. Biochem J 262:109-118.
11. Handa M, Choi D, Caldeiro RM, Messing RO, Gordon AS, and Diamond II (2001) Cloning of a novel isoform of the mouse NBMPR-sensitive equilibrative nucleoside transporter (ENT1) lacking a putative phosphorylation site. Gene 262:301-307.
12. Hyde RJ, Cass CE, Young JD, and Baldwin SA (2001) The ENT family of eukaryote nucleoside and nucleobase transporters: recent advances in the investigation of structure/function relationships and the identification of novel isoforms. Mol Membr Biol 18:53-63.
13. King AE, Ackley MA, Cass CE, Young JD, and Baldwin SA (2006) Nucleoside transporters: from scavengers to novel therapeutic targets. Trends Pharmacol Sci 27:416-425.
14. Kiss A, Farah K, Kim J, Garriock RJ, Drysdale TA, and Hammond JR (2000) Molecular cloning and functional characterization of inhibitor-sensitive (MENT1) and inhibitor-resistant (MENT2) equilibrative nucleoside transporters from mouse brain. Biochem J 352:363-372.
15. Kwong FYP, Wu J-S R, Shi MM, Fincham HE, Davies A, Henderson PJF, Baldwin SA, and Young JD (1993) Enzymic cleavage as a probe of the molecular structures of mammalian equilibrative nucleoside transporters. J Biol Chem 268:22127-22134.
16. Paterson ARP, and Oliver JM (1971) Nucleoside transport. II. Inhibition by P-nitrobenzylthioguanosine and related compounds. Can J Biochem 49:271-274.
17. Robillard K, Patrianakos V, and Hammond JR (2006) A novel splice variant of the equilibrative nucleoside transporter 1 (ENT1). Acta Pharmacologica Sinica 27(Suppl 1):391.
18. Shi MM, Wu J-SR, Lee C-M, and Young JD (1984) Nucleoside transport: photoaffinity labelling of high-affinity nitrobenzylthioinosine binding sites in rat and guinea pig lung. Biochem Biophys Res Commun 118:594-600.
19. Stolk M, Cooper E, Vilk G, Litchfield DW, and Hammond JR (2005) Subtype-specific regulation of equilibrative nucleoside transporters by protein kinase CK2. Biochem J 386:281-289.
20. Valdés R, Liu W, Ullman B, and Landfear SM (2006) Comprehensive examination of charged intramembrane residues in a nucleoside transporter. J Biol Chem 281:22647-22655.
21. Vickers MF, Mani RS, Sundaram M, Hogue DL, Young JD, Baldwin SA, and Cass CE (1999) Functional production and reconstitution of the human equilibrative nucleoside transporter (HENT1) in Saccharomyces cerevisiae. Interaction of inhibitors of nucleoside transport with recombinant Hent1 and a glycosylation-defective derivative (Hent1/N48q). Biochem J 339:21-32.
22. Visser F, Baldwin SA, Isaac RE, Young JD, and Cass CE (2005a) Identification and mutational analysis of amino acid residues involved in dipyridamole interactions with human and Caenorhabditis elegans equilibrative nucleoside transporters. J Biol Chem 280:11025- 11034.
23. Visser F, Sun L, Damaraju V, Tackaberry T, Peng Y, Robins MJ, Baldwin SA, Young JD, and Cass CE (2007) Residues 334 and 338 in transmembrane segment 8 of human equilibrative nucleoside transporter 1 are important determinants of inhibitor sensitivity, protein folding and catalytic turnover. J Biol Chem 282:14148-14157.
24. Visser F, Zhang J, Raborn RT, Baldwin SA, Young JD, and Cass CE (2005b) Residue 33 of human equilibrative nucleoside transporter 2 is a functionally important component of both the dipyridamole and nucleoside binding sites. Mol Pharmacol 67:1291-1298.
25. Vyas S, Ahmadi B, and Hammond JR (2002) Complex effects of sulfhydryl reagents on ligand interactions with nucleoside transporters: evidence for multiple populations of ENT1 transporters with differential sensitivities to N-ethylmaleimide. Arch Biochem Biophys 403:92-102.
26. Wu SK, Ann DK, Kim KJ, and Lee VH (2005) Fine tuning of rabbit equilibrative nucleoside transporter activity by an alternatively spliced variant. J Drug Target 13:521-533.
27. Yao SY, Ng AM, Muzyka WR, Griffiths M, Cass CE, Baldwin SA, and Young JD (1997) Molecular cloning and functional characterization of nitrobenzylthioinosine (NBMPR)-sensitive (Es) and NBMPR-insensitive (Ei) equilibrative nucleoside transporter proteins (RENT1 and RENT2) from rat tissues. J Biol Chem 272:28423-28430.
28. 6-(p-azidobenzyl)adenosine and nitrobenzylthioinosine: evidence that the transporter is a band 4.5 polypeptide. J Biol Chem 258:2202-2208.
29. Zhang J, Visser F, King KM, Baldwin SA, Young JD, and Cass CE (2007) The role of nucleoside transporters in cancer chemotherapy with nucleoside drugs. Cancer Metastasis Rev 26:85-110.
30. Zhu Z, Furr J, and Buolamwini JK (2003) Synthesis and flow cytometric evaluation of novel 1,2,3,4-tetrahydroisoquinoline conformationally constrained analogues of nitrobenzylmercaptopurine riboside (NBMPR) designed for probing its conformation when bound to the es nucleoside transporter. J Med Chem 46:831-837.